Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Based on studies in mice, MECP2 binds to the promoter region...

Class:IdSummation:9615804
_displayNameBased on studies in mice, MECP2 binds to the promoter region...
_timestamp2018-08-08 14:48:23
created[InstanceEdit:9615811] Orlic-Milacic, Marija, 2018-08-08
literatureReference[LiteratureReference:9615815] Reduction of aberrant NF-κB signalling ameliorates Rett syndrome phenotypes in Mecp2-null mice
modified[InstanceEdit:9615825] Orlic-Milacic, Marija, 2018-08-08
textBased on studies in mice, MECP2 binds to the promoter region of IRAK1 gene, encoding a serine/threonine protein kinase involved in activation of NFKB-mediated transcription. MECP2-mediated regulation of IRAK1 transcription may be specific to cortical neurons (Kishi et al. 2016).
(summation)[Reaction:9615801] MECP2 binds IRAK1 gene [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Based on studies in mice, MECP2 binds to the promoter region... (9615804)